Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Moving Beyond the 'One Disease, One Drug' Paradigm to Navigate Neurodegenerative Disease Complexity
Expert Insights: Innovative Discovery Strategies for Proteinopathies
Scientific poster: Evaluation of human iPSC derived triculture as in vitro model for neuroinflammation
Expert Insights: how to mitigate risk and be successful in neurodegenerative drug discovery
Research highlights: Targeted Protein Degradation in Tauopathies
Case Study: Development of a human iPSC-derived ALS model